🇺🇸 FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12319752

Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-r

Northwestern University · Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12036234

Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic

Northwestern University · Granted Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11174288

Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-r

Northwestern University · Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10251955

Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding thera

The Regents of the University of Colorado, a Body Corporate · Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9700628

Heparin-mimicking sulfonated reverse thermal gel for the delivery of heparin-binding ther

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8617557

Antibody fusion with IL-12 proteins with disrupted heparin-binding activity

The Regents of the University of California · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851445

Angiogenic heparin-binding epitopes, peptide amphiphiles, self-assembled compositions and

Northwestern University · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264799

Use of heparinases to decrease inflammatory response

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6787365

Inhibition of L-selectin and P-selectin mediated binding using heparin

The Regents of the University of California · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6596705

Inhibition of L-selectin and P-selection mediated binding using heparin

The Regents of the University of California · Granted Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6051549

Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired